Trials / Terminated
TerminatedNCT04317586
Trident II Revision Outcomes Study
A Prospective, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Trident II Acetabular Shell in a Revision Indication
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Stryker Orthopaedics · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to review the performance and success rate of an FDA cleared cementless hip replacement part called the Trident II Tritanium Acetabular Shell. The study will specifically look at the need to revise the hip replacement after 5 years. This will be compared to how much this happens in patients who have hip replacement with similar cementless acetabular shells.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Trident II Tritanium Acetabular Shell for Revision | A hemispherical acetabular shell indicated for cementless application in a previously failed total hip arthroplasty (THA) |
Timeline
- Start date
- 2020-06-23
- Primary completion
- 2023-01-27
- Completion
- 2023-01-27
- First posted
- 2020-03-23
- Last updated
- 2023-12-01
- Results posted
- 2023-12-01
Locations
10 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04317586. Inclusion in this directory is not an endorsement.